The NIDDK Hematology Centers Program is providing a novel support mechanism for researchers to pursue new directions in non-malignant hematology. New Type B Pilot and Feasibility Funding applications will be accepted through September 16, 2024, 5:00pm MT.
Yale Center of Excellence in Hematology Director Diane Krause, MD, PhD is speaking for the Max Wintrobe Endowed Lecture “Mechanisms of Hematopoietic Fate Specification to Megakaryocytes”
Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis
Complexity of active signaling pathways contributing to altered hematopoiesis
Applications for the 2025 Utah U54 Center of Excellence in Hematology CIHD Postdoc/Student Training are due.
Engineering complex human preclinical models of haematopoiesis
Determinants of Maternal-Fetal Iron Partitioning – New Approaches and Unresolved Questions
Effects of somatic mutations on developmental and adult hematopoiesis
Iron Chelation Improves Erythropoiesis in Myelodysplastic Syndrome
Characterization of the activation of NLK in Diamond Blackfan Anemia